1. Home
  2. AVBP vs NBBK Comparison

AVBP vs NBBK Comparison

Compare AVBP & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • NBBK
  • Stock Information
  • Founded
  • AVBP 2021
  • NBBK 1892
  • Country
  • AVBP United States
  • NBBK United States
  • Employees
  • AVBP N/A
  • NBBK N/A
  • Industry
  • AVBP
  • NBBK
  • Sector
  • AVBP
  • NBBK
  • Exchange
  • AVBP NYSE
  • NBBK Nasdaq
  • Market Cap
  • AVBP 925.7M
  • NBBK 783.2M
  • IPO Year
  • AVBP 2024
  • NBBK N/A
  • Fundamental
  • Price
  • AVBP $27.52
  • NBBK $17.85
  • Analyst Decision
  • AVBP Strong Buy
  • NBBK Buy
  • Analyst Count
  • AVBP 5
  • NBBK 1
  • Target Price
  • AVBP $36.80
  • NBBK $22.00
  • AVG Volume (30 Days)
  • AVBP 152.3K
  • NBBK 194.7K
  • Earning Date
  • AVBP 02-02-2025
  • NBBK 02-27-2025
  • Dividend Yield
  • AVBP N/A
  • NBBK N/A
  • EPS Growth
  • AVBP N/A
  • NBBK N/A
  • EPS
  • AVBP N/A
  • NBBK 0.30
  • Revenue
  • AVBP N/A
  • NBBK $146,994,000.00
  • Revenue This Year
  • AVBP N/A
  • NBBK N/A
  • Revenue Next Year
  • AVBP N/A
  • NBBK N/A
  • P/E Ratio
  • AVBP N/A
  • NBBK $60.34
  • Revenue Growth
  • AVBP N/A
  • NBBK 11.94
  • 52 Week Low
  • AVBP $14.35
  • NBBK $13.26
  • 52 Week High
  • AVBP $36.37
  • NBBK $21.05
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 50.18
  • NBBK 31.47
  • Support Level
  • AVBP $26.36
  • NBBK $18.00
  • Resistance Level
  • AVBP $27.67
  • NBBK $18.40
  • Average True Range (ATR)
  • AVBP 1.27
  • NBBK 0.56
  • MACD
  • AVBP 0.18
  • NBBK -0.19
  • Stochastic Oscillator
  • AVBP 71.82
  • NBBK 8.61

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About NBBK NB Bancorp Inc.

NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.

Share on Social Networks: